Cargando…

Isorhamnetin Attenuated the Release of Interleukin-6 from β-Amyloid-Activated Microglia and Mitigated Interleukin-6-Mediated Neurotoxicity

Alzheimer's disease (AD), characterized by the abnormal accumulation of β-amyloid (Aβ), is the most prevalent type of dementia, and it is associated with progressive cognitive decline and memory loss. Aβ accumulation activates microglia, which secrete proinflammatory factors associated with Aβ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Pei-Cih, Lee-Chen, Guey-Jen, Chen, Chiung-Mei, Chen, Ying, Lo, Yen-Shi, Chang, Kuo-Hsuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499806/ https://www.ncbi.nlm.nih.gov/pubmed/36160711 http://dx.doi.org/10.1155/2022/3652402

Ejemplares similares

Interleukin 13 on Microglia is Neurotoxic in Lipopolysaccharide-injected Striatum in vivo
por: Hong, Ah Reum, et al.
Publicado: (2022)

Polymorphisms of Interleukin-6 and Interleukin-8 Are Not Associated with Parkinson’s Disease in Taiwan
por: Liu, Tsai-Wei, et al.
Publicado: (2021)

Serum amyloid A primes microglia for ATP-dependent interleukin-1β release
por: Facci, Laura, et al.
Publicado: (2018)

Interleukin-6 and Interleukin-8 Regulate STAT3 Activation Migration/Invasion and EMT in Chrysophanol-Treated Oral Cancer Cell Lines
por: Hsu, Po-Chih, et al.
Publicado: (2021)

The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
por: West, Phillip K., et al.
Publicado: (2022)

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
por: Ferreros, Puri, et al.
Publicado: (2022)

Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1993)

Role of Interleukin-6 in Depressive Disorder
por: Ting, Emily Yi-Chih, et al.
Publicado: (2020)

Brain Cells Release Calreticulin That Attracts and Activates Microglia, and Inhibits Amyloid Beta Aggregation and Neurotoxicity
por: Reid, Kyle M., et al.
Publicado: (2022)

Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritis
por: Suyasa, I Ketut, et al.
Publicado: (2017)

Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates
por: González-Arceo, Maitane, et al.
Publicado: (2022)

Serum amyloid A (SAA) and Interleukin-6 (IL-6) as the potential biomarkers for gastric cancer
por: Hou, Yongwang, et al.
Publicado: (2022)

Midazolam suppresses interleukin-1β-induced interleukin-6 release from rat glial cells
por: Tanabe, Kumiko, et al.
Publicado: (2011)

Interleukin-6 Expression by Hypothalamic Microglia in Multiple Inflammatory Contexts: A Systematic Review
por: Bobbo, Vanessa C. D., et al.
Publicado: (2019)

Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor
por: Suzumura, Akio, et al.
Publicado: (1996)

Modification of the Interleukin-6 Response to Air Pollution by Interleukin-6 and Fibrinogen Polymorphisms
por: Ljungman, Petter, et al.
Publicado: (2009)

Isorhamnetin Enhances the Radiosensitivity of A549 Cells Through Interleukin-13 and the NF-κB Signaling Pathway
por: Du, Yarong, et al.
Publicado: (2021)

Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models
por: Wei, Pei-Cih, et al.
Publicado: (2019)

Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)
por: Chen, Jia-Jie, et al.
Publicado: (2021)

Interleukin-6 released by oral lichen planus myofibroblasts promotes angiogenesis
por: Xu, Xiao-Heng, et al.
Publicado: (2021)

Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19
por: Luo, Kuan, et al.
Publicado: (2021)

Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease
por: Chen, Shih-Yuan, et al.
Publicado: (2012)

Platelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia
por: Sattayaprasert, Prasongchai, et al.
Publicado: (2005)

Isorhamnetin Influences the Viability, Superoxide Production and Interleukin-8 Biosynthesis of Human Colorectal Adenocarcinoma HT-29 Cells In Vitro
por: Greifová, Hana, et al.
Publicado: (2023)

High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder
por: Lu, Yun-Rong, et al.
Publicado: (2019)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Interleukin-6 and chronic inflammation
por: Gabay, Cem
Publicado: (2006)

Interleukin-6 and rheumatic diseases
por: Lipsky, Peter E
Publicado: (2006)

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

The Role of Interleukin-6 in Bone
por: Lorenzo, Joseph A
Publicado: (2020)

Interleukin-6 and intrapulmonary shunt
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2021)

Assessing the importance of interleukin-6 in COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Amyloid β peptide-mediated neurotoxicity is attenuated by the proliferating microglia more potently than by the quiescent phenotype
por: Tsay, Huey-Jen, et al.
Publicado: (2013)

Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms
por: Kao, Hung-Wen, et al.
Publicado: (2015)

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
por: Widjaja, Anissa A., et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation
por: Salvatierra, Juan, et al.
Publicado: (2021)

Interleukin-6: an emerging regulator of pathological pain
por: Zhou, Ya-Qun, et al.
Publicado: (2016)

Effect of Interleukin 6 Deficiency on Renal Interstitial Fibrosis
por: Yang, Jun, et al.
Publicado: (2012)

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes
por: Kang, Liqing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tk9ooqq11khjpuj6vhs203i1ev